About BIOAGE LABS
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, Azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with Tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
Open positions (2)
Company details
Funding
Total raised
$297
Last stage
Growth
Investors
Founders
Kristen Fortney
PhD; formerly a postdoctoral research fellow at Stanford University studying the genetics of extreme human longevity. Co-founded BioAge in 2015.
LinkedInEric Morgen
MD; co-founded BioAge Labs alongside Kristen Fortney in 2015 and previously served as CMO before becoming COO.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.